GlassScriptPhysician profile
Patrice L Staten
NPI 1154481364
$760.99
in general payments reported to CMS, 2019-2025
17 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $54.19 · 2021: $31.26 · 2023: $111 · 2024: $191 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $465.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $131.23 | 2020-2025 | Slynd |
| Daiichi Sankyo INC. | $85.88 | 2019-2020 | |
| Abbvie INC. | $77.11 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Amgen INC. | $76.66 | 2023-2025 | Evenity, Prolia |
| Astellas Pharma US INC | $63.89 | 2023-2024 | Veozah, Myrbetriq |
| Channel Medsystems, INC. | $41.67 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.13 | 2019-2025 | |
| Organon LLC | $39.83 | 2024 | |
| Amag Pharmaceuticals, INC. | $36.47 | 2019 | |
| Millicent US INC | $31.85 | 2025 | Intrarosa, Femlyv |
| Smith+Nephew, INC. | $29.99 | 2019 | |
| Dexcom, INC. | $22.53 | 2024 | Dexcom G6 Transmitter |
| Mayne Pharma Commercial LLC | $21.12 | 2021-2023 | |
| Exact Sciences Corporation | $18.21 | 2025 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $16.61 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalpropion Pharmaceuticals LLC | $14.67 | 2019 | |
| Lupin INC. | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrice Staten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.